The top five holdings of this Morningstar three-star-rated fund are: BioTelemetry Inc (BEAT, 4.78% of assets); Vericel Corp (VCEL, 4.64%); CareDx Inc (CDNA, 4.43%); Fluidigm Corp (FLDM, 4.14%); and AtriCure Inc (ATRC, 4.08%).
Perkins Discovery Fund (PDFDX)
From The Chartist Mutual Fund/ETF Letter
Perkins Discovery Fund (PDFDX) was founded in 04/00, right at the top of the tech bubble. Its three-year Morningstar rating is a 5.
It has $30.7 million under management with a hefty net expense ratio of 2.5%, and is a Schwab no load, no transaction fee fund. There is a Schwab fee if the fund is sold within 90 days.
Its focus is on specialty-health funds in the medical and health care industries. Since the inception of our database 9/1/1988, the health care industry has been a stellar performer with our aging population, growing affluence, and advances in all forms of medical treatment. The fund is certainly focused in a popular sector. Its investments are 69.7% health care, 18.3% information, 6.2% consumer discretionary and 1.8% communication services. The return for the 67 day ranking period is 34.7%, three months 25.4% and five years 66.6%.
Dan Sullivan, The Chartist Mutual Fund/ETF Letter, www.thechartist.com, 900-942-4278, April 4, 2019